Reginster, J. Y., & Burlet, N. Osteoporosis: a still increasing prevalence. Bone 2006;38(2 Suppl 1), S4–S9. https://doi.org/10.1016/j.bone.2005.11.024
DOI: 10.1016/j.bone.2005.11.024
LATAM AUDIT 2021. Epidemiología, costo e impacto de la osteoporosis y las fracturas por fragilidad Available at https://www.osteoporosis.foundation/sites/iofbonehealth/files/2022-08/LATAM%20Audit%202021%20-%20FINAL.pdf accessed 21 Jan 2023
Quevedo I, Ormeño JC, Weissglas B, Opazo C. Epidemiology and Direct Medical Cost of Osteoporotic Hip Fracture in Chile. J Osteoporos 2020;2020:5360467
DOI: 10.1155/2020/5360467
Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17(7):1237-44.
DOI: 10.1359/jbmr.2002.17.7.1237
Kanis JA, Cooper C, Rizzoli R, Reginster J-Y; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2019;30(1):3–44
DOI: 10.1007/s00198-018-4704-5
Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Rev Bras Reumatol Engl Ed. 2017;57 (Suppl 2):452-466.
DOI: 10.1016/j.rbre.2017.07.001
Diagnóstico y tratamiento de osteoporosis en mujeres posmenopáusicas. Actualización 2018. Disponible en https://www.imss.gob.mx/sites/all/statics/guiasclinicas/673GER.pdf
Schurman L, Galich AM, González C, González D, Messina OD, Sedlinsky C, et al. Guías Argentinas para el Diagnóstico, la Prevención y el Tratamiento de la Osteoporosis MEDICINA (Buenos Aires) 2017;77: 46-60
Arinoviche Schenker R, Arinoviche Numhauser, Arriagada Maldini M, Campusano M C, Fuentealba Perez C, Gajardo Lamas H, et al. Nueva guía SCHOMM 2018. Guías de diagnóstico, prevención y tratamiento de la osteoporosis. Disponible en http://schomm.cl/Pdfs/SCHOMM_Guias2018_Final.pdf Sociedad Chilena de Osteología y Metabolismo Mineral. consultado 21september 2021
Medina Orjuela A, Rosero Olarte O, Rueda Plata PN, Sánchez Escobar F, Chalem Chouekae M, González Reyes MA, et al. II Consenso Colombiano para el Manejo de la Osteoporosis Posmenopáusica. Rev colomb reumatol. 2018;25(3):184–210
DOI: 10.1016/j.rcreu.2018.02.006
Prevención, diagnóstico y tratamiento de la osteoporosis [2019]. Guía de Consulta Para el Médico de Primer Nivel de Atención. Secretaria de Salud de México. disponible en: cenetec-difusion.com/gpc-sns/wp-content/uploads/2019/06/GuiaConsulta_Osteoporosis.pdf
Li-Yu J, Lekamwasam S. Intervention thresholds to identify postmenopausal women with high fracture risk: A single center study based on the Philippines FRAX model. Osteoporos Sarcopenia. 2021;7(3):98-102.
DOI: 10.1016/j.afos.2021.09.003
Clark P, Denova-Gutiérrez E, Zerbini C, Sanchez A, Messina O, Jaller JJ, et al. FRAX-based intervention and assessment thresholds in seven Latin American countries. Osteoporos Int. 2018;29(3):707-715.
DOI: 10.1007/s00198-017-4341-4
Zerbini CA, Szejnfeld VL, Abergaria BH, McCloskey EV, Johansson H, Kanis JA. Incidence of hip fracture in Brazil and the development of a FRAX model. Arch Osteoporos 2015;10:224. https://doi.org/10.1007/s11657-015-0224-5
DOI: 10.1007/s11657-015-0224-5
Jaller-Raad JJ, Jaller-Char JJ, Lechuga-Ortiz JA, Navarro-Lechuga E, Johansson H, Kanis JA. Incidence of hip fracture in Barranquilla, Colombia, and the development of a Colombian FRAX model. Calcif Tissue Int. 2013;93(1):15-22.
DOI: 10.1007/s00223-013-9717-7
Lopez Gavilanez E, Johansson H, McCloskey E, Harvey N. C, Segale Bajana A, Marriott Blum D, et al. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model. Arch Osteoporos 2019;14(1):93.
DOI: 10.1007/s11657-019-0644-8
Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23(9):2239-56.
DOI: 10.1007/s00198-012-1964-3
McCloskey E, Kanis JA, Johansson H, Harvey N, Oden A, Cooper A, et al. FRAX-based assessment and intervention thresholds–an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 2015;26:2091–2099
DOI: 10.1007/s00198-015-3176-0
Chakhtoura M, Leslie WD, McClung M, Cheung AM, Fuleihan GE. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model. Osteoporos Int. 2017;28(1):127-137
DOI: 10.1007/s00198-016-3766-5
Goldshtein I, Ish-Shalom S, Leshno M. Impact of FRAX-based osteoporosis intervention using real world data. Bone 2017;103: 318–324.
DOI: 10.1016/j.bone.2017.07.027
Kanis JA, Har vey NC, Cooper C, Johansson H, Oden A , McCloskey EV. A systematic review of intervention thresholds based on FRAX: a report prepared for the national osteoporosis guideline group and the International Osteoporosis Foundation. Arch Osteoporos 2016;11(1):25.
DOI: 10.1007/s11657-016-0278-z
López Gavilánez E, Johansson H, Harvey N, Lorentzon M, McCloskey E, Valdivieso Jara J, Kanis JA. The application of FRAX in Ecuador. Rev Colomb Reumatol. 2021 https://doi.org/10.1016/j.rcreu.2021.07.004
DOI: 10.1016/j.rcreu.2021.07.004
Departamento de Epidemiología (1). Ministerio de Salud. Gobierno de Chile. Encuesta Nacional de Salud (ENS) 2016 - 2017. 2018 [disponible en: http://epi.minsal.cl/encuesta-ens-descargable/.
Departamento de Epidemiología (2). Ministerio de Salud. Gobierno de Chile. Encuesta Nacional de Salud 2016-2017. 2018 [disponible en: http://epi.minsal.cl/encuesta-nacional-de-salud-2015-2016/.
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. Case finding for the management of osteoporosis with FRAX–assessment and intervention thresholds for the UK.
Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 2017;12(1):43 https://doi.org/10.1007/s11657-017-0324-5
DOI: 10.1007/s11657-017-0324-5
Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31(1):1-12.
DOI: 10.1007/s00198-019-05176-3
Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, et al. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas. 2009;62(2):105-108.
DOI: 10.1016/j.maturitas.2008.11.022
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033–46 . https://doi.org/10.1007/s00198-007-0343-y
DOI: 10.1007/s00198-007-0343-y
Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, et al; Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182(17):1864-1873.
DOI: 10.1503/cmaj.100771
Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician‘s guide to prevention and treatment of osteoporosis. Osteoporos Int 2014;25:2359–2381 https://doi.org/10.1007/s00198-014-2794-2
DOI: 10.1007/s00198-014-2794-2
Johansson H, Oden A, Johnell O,Jonsson B, de Laet C, Oglesby A, et al. Optimization of BMD measurements to identify high risk groups for treatment--a test analysis. J Bone Miner Res. 2004;19(6):906-913.
DOI: 10.1359/jbmr.2004.19.6.906
Sale JEM, Gray M, Mancuso D, Inrig T, Boire G, Beaulieu MC, Funnell L, Bogoch E. Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelines. Rheumatol Int. 2018;38(12):2193-2208
DOI: 10.1007/s00296-018-4181-3
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. How to decide who to treat. Best Pract Res Clin Rheumatol. 2009;23(6):711-726.
DOI: 10.1016/j.berh.2009.09.002
Kanis JA, Adams J, Borgström F, Cooper C, Jönsson B, Preedy D, et al. The cost-effectiveness of alendronate in the management of osteoporosis. Bone. 2008;42(1):4-15.
DOI: 10.1016/j.bone.2007.10.019